Article Versions Notes

Lee C-L, Chen W-S, Wee Y, Wang C-S, Chen W-C, Chiu T-J, Wang Y-M, Wu C-N, Yang Y-H, Luo S-D, et al. Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers. 2022; 14(3):703. https://doi.org/10.3390/cancers14030703

Lee, Chien-Lin, Wei-Shan Chen, Yinshen Wee, Ching-Shuen Wang, Wei-Chih Chen, Tai-Jan Chiu, Yu-Ming Wang, Ching-Nung Wu, Yao-Hsu Yang, Sheng-Dean Luo, and et al. 2022. "Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers" Cancers 14, no. 3: 703. https://doi.org/10.3390/cancers14030703

Lee, C.-L., Chen, W.-S., Wee, Y., Wang, C.-S., Chen, W.-C., Chiu, T.-J., Wang, Y.-M., Wu, C.-N., Yang, Y.-H., Luo, S.-D., & Wu, S.-C. (2022). Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers, 14(3), 703. https://doi.org/10.3390/cancers14030703